US markets rebound

Ahead of Federal Reserve minutes this evening, US markets are notching up small gains, while the FTSE continues to labour in the red.

Wall street sign
Source: Bloomberg

Insurers weigh on FTSE

Insurers have conspired to keep the FTSE down today, after Admiral dived 6.7% and took the rest of the sector with it. The trading update this morning rather scuppered the rally in the share price, which had until yesterday stood at three-year highs. Evidently the company has aimed at getting the bad news out of the way, and the sound of earnings revisions could be heard across the City today, but Admiral will need to plot a steady course now to avoid taking on more water.

Aviva disappointed too, after its new targets were deemed insufficiently ambitious, an odd fate for a company whose previous hubris was widely derided. 

US markets bounce back

US markets steadied the ship this afternoon after two steep days of declines, but all this is made in the face of Fed minutes that could easily upset the delicate balance.

At least Alcoa has done well, getting earnings season off to an impressive start. Its shareholders should continue to thank the Dow Jones for booting their company out of the index, as Alcoa shares have gained over 40% this year, versus a miserly 2.2% for the Dow.

Once again the Dow is keeping a healthy distance between itself and the 20-day moving average – at present it seems that the louder the calls for a correction become, the smaller the dips get.

Brent sheds June gains

The breakdown in oil prices has seen both Brent and NYMEX shed almost all their June gains, as Libyan supplies come back onto the market and remove yet another of the props that supported the price during its summer rally. Seasonality issues may help to lift the commodity in the short term, as the summer holiday gets underway in the US, but unless the level of tension in Iraq is ratcheted up several notches there seems little to lift oil from its current doldrums. Brent’s target is now $108, while NYMEX is fighting for its 100-day moving average at $102.40.

Euro finds buyers

EUR/USD is doing its best to shrug off the ‘death cross’ witnessed at the end of last week, as it continues to find buyers around $1.3640, but these gains are being made with a nervous eye on the Fed minutes this evening. Any hawkish tone here could see the euro gains evaporate rapidly and signal a new attempt to head towards $1.35.

Meanwhile the pound is little changed versus the dollar, but even a surprise set of minutes would likely only see it slip back towards $1.70, as it deals with the weaker UK economic data seen yesterday. 


IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.